This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Durán-Prado, M. Articles by Castaño, J. P. Search for Related Content PubMed PubMed Citation Articles by Durán-Prado, M. Articles by Castaño, J. P.

Porcine Somatostatin Receptor 2 Displays Typical Pharmacological sst2 Features but Unique Dynamics of Homodimerization and Internalization

Department of Cell Biology, Physiology and Immunology (M.D.-P., R.V.-M., A.J.M.-F., S.G.-N., M.M.M., J.P.C.), University of Córdoba, E-14014 Córdoba, Spain; Laboratory of Cellular and Molecular Neuroendocrinology, European Institute for Peptide Research (C.B., B.J.G., H.V.), University of Rouen, 76821 Mont-Saint-Aignan, Cedex, France; and Department of Cellular and Integrative Physiology (S.J.R.), Indiana University School of Medicine, Indianapolis, Indiana 46202

Address all correspondence and requests for reprints to: Dr. Justo P. Castaño, Department of Cell Biology, Physiology and Immunology, Campus de Rabanales, Edificio C-6, Planta 3, University of Córdoba, E-14014 Córdoba, Spain. E-mail: justo{at}uco.es.

Somatostatin (SRIF) exerts its multiple actions, including inhibition of GH secretion and of tumoral growth, through a family of five receptor subtypes (sst1-sst5). We recently reported that an sst2-selective agonist markedly decreases GH release from pig somatotropes, suggesting important roles for this scarcely explored receptor, psst2. Here, functional expression of psst2 in Chinese hamster ovary-K1 and human embryonic kidney-293-AD cell lines was employed to determine its pharmacological features and functional ability to reduce cAMP, and to examine its homodimerization and internalization dynamics in real time in single living cells. Results show that psst2 is a high-affinity receptor (dissociation constant = 0.27 nM) displaying a typical sst2 profile (nM affinity for SRIF-14SRIF-28>cortistatin>MK678>octreotide) and high selectivity (EC₅₀ = 1.1 nM) for the sst2 agonist L-779,976, but millimolar or undetectable affinity to other sst-specific agonists (sst3>sst1>sst5sst4). Accordingly, SRIF dose-dependently inhibited forskolin-stimulated cAMP with high potency (EC₅₀ = 6.55 pM) and modest efficacy (maximum 29.1%) via psst2. Cotransfection of human embryonic kidney-293 and Chinese hamster ovary-K1 cells with two receptor constructs modified with distinct fluorescent tags (psst2-YFP/psst2-CFP) enabled fluorescence resonance energy transfer measurement of physical interaction between psst2 receptors and also receptor internalization in single living cells. This revealed that under basal conditions, psst2 forms constitutive homodimers/homomultimers, which dissociate immediately (11 sec) upon SRIF binding. Interestingly, contrary to human sst2, psst2 rapidly reassociates (110.5 sec) during a subsequent process that temporally overlaps with receptor internalization (half-maximal = 95.1 sec). Therefore, psst2 is a potent inhibitory receptor displaying a unique set of interrelated dynamic features of agonist-dependent dimerization, dissociation, internalization, and reassociation, a cascade of events that might be critical for receptor function.

This article has been cited by other articles:

				M. Duran-Prado, M. D. Gahete, A. J. Martinez-Fuentes, R. M. Luque, A. Quintero, S. M. Webb, P. Benito-Lopez, A. Leal, S. Schulz, F. Gracia-Navarro, et al. Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2634 - 2643. [Abstract] [Full Text] [PDF]

				M. Grant, H. Alturaihi, P. Jaquet, B. Collier, and U. Kumar Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization Mol. Endocrinol., October 1, 2008; 22(10): 2278 - 2292. [Abstract] [Full Text] [PDF]